Response to flavone acetic acid (NSC 347512) of primary and metastatic human colorectal carcinoma xenografts

Br J Cancer. 1988 Mar;57(3):277-80. doi: 10.1038/bjc.1988.59.

Abstract

The antitumour activity of flavone acetic acid (FAA) was evaluated against two human colorectal carcinoma (HCC) lines, HCC-P2988 and HCC-M1410, transplanted into nude mice. On repeated i.v. injection of 200 mg kg-1 every 4 days FAA was moderately active against the s.c. growing HCC-P2988. HCC-M1410 transplanted s.c. was almost unresponsive in the same experimental conditions. In contrast, FAA (200 mg kg-1 i.v. every 4 days, repeated three times) significantly reduced liver tumour colonies produced by the HCC-M1410 cells injected intrasplenically into nude mice. These findings suggest that FAA has potential activity against human colorectal carcinoma, particularly against liver metastases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Flavonoids / therapeutic use*
  • Humans
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / secondary
  • Male
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Rectal Neoplasms / drug therapy*
  • Transplantation, Heterologous

Substances

  • Antineoplastic Agents
  • Flavonoids
  • flavone acetic acid